-+ 0.00%
-+ 0.00%
-+ 0.00%

Allergy Therapeutics Announces Annual General Meeting

PUBT·11/17/2026 07:29:23
Listen to the news
Allergy Therapeutics Announces Annual General Meeting
  • Allergy Therapeutics will hold its annual general meeting at DLA Piper's London offices on December 14, 2026.
  • Shareholders will vote on canceling AIM trading and re-registering as a private limited company with new articles of association.
  • Cancellation is expected December 22, 2026; re-registration is targeted for the week beginning January 11, 2027.
  • SkyGem and Southern Fox, holding 87.98% of issued shares, intend to support both proposals.
  • A JP Jenkins matched bargain facility would support share trading for at least 12 months following cancellation.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allergy Therapeutics plc published the original content used to generate this news brief on November 17, 2026, and is solely responsible for the information contained therein.